Orest Szczurko

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. pmc A systematic review of natural health product treatment for vitiligo
    Orest Szczurko
    Leslie Dan Faculty of Pharmacy, University of Toronto, Canada
    BMC Dermatol 8:2. 2008
  2. pmc Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial
    Orest Szczurko
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, 130 Dundas St East, Suite 305, Mississauga, ON L5A 3V8, Canada
    BMC Complement Altern Med 11:21. 2011

Detail Information

Publications2

  1. pmc A systematic review of natural health product treatment for vitiligo
    Orest Szczurko
    Leslie Dan Faculty of Pharmacy, University of Toronto, Canada
    BMC Dermatol 8:2. 2008
    ..Vitiligo is a hypopigmentation disorder affecting 1 to 4% of the world population. Fifty percent of cases appear before the age of 20 years old, and the disfigurement results in psychiatric morbidity in 16 to 35% of those affected...
  2. pmc Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial
    Orest Szczurko
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, 130 Dundas St East, Suite 305, Mississauga, ON L5A 3V8, Canada
    BMC Complement Altern Med 11:21. 2011
    ..Vitiligo is a common hypopigmentation disorder with significant psychological impact if occurring before adulthood. A pilot clinical trial to determine the feasibility of an RCT was conducted and is reported here...